Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Emre, Odabaş"'
Autor:
Emre ODABAŞ, Ajda GÜNEŞ, Nur SOYER, Mahmut TOBU, Fahri ŞAHİN, Güray SAYDAM, BİLGİN ARDA, Filiz VURAL
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 12, Iss 4, Pp 310-317 (2024)
Aim: The incidence of invasive fungal infection (IFI) is high in patients undergoing allogeneic hematopoietic stem cell transplantation. Despite new antifungal agents, IFI is still an important cause of mortality. Our study aimed to determine the ris
Externí odkaz:
https://doaj.org/article/97824bb2c1904ca799597b8bc833ea02
Autor:
Ümit Karaoğullarından, Yüksel Gümürdülü, Oğuz Üsküdar, Emre Odabaş, Hasan Selim Güler, Cansu Geçkalan, Burcu Aslan Benli, Anıl Delik, Asena Ayça Özdemir, Sedef Kuran
Publikováno v:
The Turkish Journal of Gastroenterology, Vol 35, Iss 3, Pp 204-211 (2024)
Background/Aims: Hepatocellular carcinoma is a major cause of mortality and morbidity in both cirrhotic and non-cirrhotic patients, and most patients are suitable for locoregional and/or systemic therapy at the time of diagnosis. In this study, we ai
Externí odkaz:
https://doaj.org/article/8ab6a9be41344fd595e287bb50f622d7
Publikováno v:
The Turkish Journal of Gastroenterology, Vol 34, Iss 3, Pp 262-269 (2023)
Externí odkaz:
https://doaj.org/article/6d14b86dc91b42548ade06ff0fb96891
Autor:
Ümit, Karaoğullarindan, Yüksel, Gümürdülü, Oguz, Üsküdar, Emre, Odabaş, Hasan Selim, Güler, Nur, Tozluklu, Emine, Bağir, Sedef, Kuran
Publikováno v:
European Journal of Gastroenterology & Hepatology. 35:89-93
Hepatocellular carcinoma (HCC) is the seventh most common cancer all worldwide and is second in cancer-related deaths. In HCC, whose prognosis is still not good despite current treatments, there is a need for prognostic markers as well as early diagn
Autor:
Ümit, Karaoğullarindan, Yüksel, Gümürdülü, Oguz, Üsküdar, Emre, Odabaş, Hasan Selim, Güler, Anil, Delik, Sedef, Kuran
Publikováno v:
European Journal of Gastroenterology & Hepatology. 34:956-960
Hepatocellular carcinoma (HCC) is a cancer with a poor prognosis, its incidence increases with age. The risk of developing HCC is highest in the seventh decade. In this study, we aimed to determine the clinicopathological differences, treatment choic
Autor:
Fulya Odabaş, Gamze Akkus, Ferhatcan Pişkin, Emre Odabaş, Tuğsan Ballı, Umit Karaoğullarından, Tamer Tetiker
Publikováno v:
Endocrine Abstracts.
Autor:
Ümit Karaoğullarindan, Oguz Üsküdar, Emre Odabaş, Melike Saday, Gamze Akkuş, Anil Delik, Yüksel Gümürdülü, Sedef Kuran
Publikováno v:
Indian Journal of Gastroenterology.